✦ LIBER ✦

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

✍ Scribed by Elvin Kedhi; Kaiyum Sheik Joesoef; Eugene McFadden; Jochem Wassing; Carlos van Mieghem; Dick Goedhart; Pieter Cornelis Smits

Book ID: 117305979
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 120 KB
Volume: 375
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(09)62127-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Percutaneous Coronary Intervention With

Percutaneous Coronary Intervention With Second-Generation Paclitaxel-Eluting Stents Versus Everolimus-Eluting Stents in United States Contemporary Practice (REWARDS TLX Trial)

✍ Ron Waksman; Magdi Ghali; Randy Goodroe; Thomas Ryan; Mark Turco; Michael Ring; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 641 KB

TCT-34: Everolimus-Eluting Stent Versus

TCT-34: Everolimus-Eluting Stent Versus Sirolimus- and Paclitaxel-Eluting Stents in Real-Life Practice: Pooled Analysis From the XAMI, COMPARE and APPENDIX-AMI Trials

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Impact of Lesion Length and Vessel Size

Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials

✍ Bimmer E. Claessen; Pieter C. Smits; Dean J. Kereiakes; Helen Parise; Martin Fah 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 503 KB

TCT-276: Safety and Efficacy of Everolim

TCT-276: Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents: A Meta-Analysis of 4 Trials

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 212 KB

TISSUE CHARACTERISTICS IN IN-STENT RESTE

TISSUE CHARACTERISTICS IN IN-STENT RESTENOSIS LESIONS AFTER SECOND GENERATION DRUG-ELUTING STENT IMPLANTATION: A COMPARISON BETWEEN EVEROLIMUS-ELUTING STENT AND ZOTAROLIMUS-ELUTING STENT

✍ Takeshi Tada; Kazushige Kadota; Noriyuki Ohashi; Naoki Saito; Suguru Otsuru; Dai 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 104 KB

TCT-47 Two-Year Clinical Outcome of the

TCT-47 Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

✍ Clemens von Birgelen; Kenneth Tandjung; Hanim Sen; Mounir Basalus; J. Hans Louwe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 117 KB